PMID: 29764354May 17, 2018Paper

Impact of ethnicity on the natural history of Parkinson disease

The Medical Journal of Australia
Anna SauerbierK Ray Chaudhuri

Abstract

Parkinson disease (PD) affects people of all races and ethnicity worldwide. PD is a multineurotransmitter and multisystem disorder and our current concept of the natural history of PD has changed considerably over the past decades. Many aspects of this heterogeneous condition still remain unexplained; one aspect that is poorly studied is the role of ethnicity and manifest motor and non-motor PD. Some preliminary data suggest that the prodromal risk of developing PD, clinical symptom expression and the experience of living with the condition may vary between different ethnic groups. Several factors might play a role in the influence of ethnicity on PD, such as pharmacogenetics, sociocultural aspects and environmental exposures. Increased knowledge on the role of ethnicity in PD may help shed light on the symptom expression and treatment response of PD, address inequalities in health care delivery worldwide and improve the delivery of personalised medicine.

References

Jan 1, 1990·Gerontology·K OkadaT Tsunematsu
Sep 1, 1990·Archives of Neurology·Z X ZhangN Mantel
Oct 1, 1972·American Journal of Epidemiology·I I Kessler
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Sep 24, 1994·Lancet·K JendroskaA J Lees
Sep 1, 1997·Journal of the Neurological Sciences·D J Lanska
Jun 17, 1999·Journal of Neural Transmission. Supplementum·A D Korczyn
Jan 14, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·K R ChaudhuriD J Brooks
May 18, 2000·Archives of Neurology·E D LouisQ Yu
Aug 10, 2000·Journal of the Neurological Sciences·N NagashayanaK P Mohanakumar
Mar 26, 2002·Brain : a Journal of Neurology·Dominique Caparros-LefebvreCharles Duyckaerts
Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Michele T M HuDavid J Brooks
Mar 21, 2003·The New England Journal of Medicine·Esteban González BurchardNeil Risch
Jun 20, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Zhen-Xin ZhangDemetrius M Maraganore
May 11, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Gilles AngibaudOlivier Rascol
Nov 5, 2004·The New England Journal of Medicine·Judith Aharon-PeretzRuth Gershoni-Baruch
Jun 4, 2005·Acta Neurologica Scandinavica·L ZhangK Kieburtz
Aug 11, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·John C Steele
Mar 28, 2006·Annals of Neurology·J William Langston
Jul 29, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Dominique Caparros-LefebvreShigeru Ohta
Jun 15, 2007·Archives of Neurology·Rob M A de BieAnthony E Lang
Aug 4, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Kallol Ray ChaudhuriAnthony H V Schapira
Sep 22, 2007·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Woo-Keun SeoDae-Hie Lee
Nov 29, 2007·Parkinsonism & Related Disorders·Sang-Myung CheonJae Woo Kim
Sep 26, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Annie LannuzelPatrick P Michel
May 5, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Nabila DahodwalaDavid S Mandell
May 28, 2009·JAMA : the Journal of the American Medical Association·Juliana C N ChanFrank B Hu
Jun 11, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo BaroneUNKNOWN PRIAMO study group
Aug 20, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Catherine Dotchin, Richard Walker
Oct 15, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Huijuan LiQing Wang
Dec 15, 2010·Archives of Neurology·J Patrick HemmingLisa M Shulman
Feb 23, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C-L HuangC-S Lu
Mar 16, 2011·Journal of the Neurological Sciences·M Seijo-MartinezM J Sobrido
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Glenda HallidayMatthew Stern
May 1, 2005·Environmental Toxicology and Pharmacology·Dominique Caparros-Lefebvre, John Steele
Feb 9, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Roy N AlcalayNikolaos Scarmeas
Jun 2, 2012·Expert Review of Neurotherapeutics·Catherine Dotchin, Richard Walker

❮ Previous
Next ❯

Citations

Dec 5, 2019·Frontiers in Neurology·Claudia Marisol Sánchez-MartínezParménides Guadarrama-Ortiz
Nov 6, 2020·Molecular Biology Reports·Erinaldo Ubirajara Damasceno Dos SantosPaulo Roberto Eleutério de Souza
Nov 12, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Rebecca M Gilbert, David G Standaert
May 24, 2019·Neuromolecular Medicine·Erinaldo Ubirajara Damasceno Dos SantosPaulo Roberto Eleutério de Souza
Aug 28, 2019·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M AlvesJ J Ferreira
Mar 8, 2020·Journal of Parkinson's Disease·Rauan KaiyrzhanovHenry Houlden
Jun 10, 2021·Medicinal Research Reviews·Ramón CacabelosJuan C Carril

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revue D'épidémiologie Et De Santé Publique
J ZayedM Roy
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
Ariel B NeikrugSonia Ancoli-Israel
Revista clínica española
A Gimeno Alava
© 2022 Meta ULC. All rights reserved